Core Viewpoint - The series of microfilms "Northeast True Action" produced by China Feihe captures the emotional memories of Chinese people through storytelling, emphasizing the themes of perseverance and tradition in the context of Northeast China [1][10]. Group 1: Company Overview - China Feihe has established itself as a leader in the dairy industry by focusing on self-research and production of key nutritional ingredients, significantly reducing reliance on international sources [12][13]. - The company has developed the first domestic production line for lactoferrin, mastering the production of 11 core nutritional ingredients, which strengthens the foundation of nutrition and safety [4][12]. - Feihe's commitment to quality is reflected in its 100% self-controlled farms and its innovative approach to fresh milk processing, setting new industry standards [6][12]. Group 2: Industry Context - The microfilm series illustrates the "stubborn spirit" of Northeast people and enterprises, showcasing how this resilience contributes to the industrial backbone of the nation [3][6]. - Feihe's approach contrasts with the industry trend of adopting light-asset models, as it emphasizes full control over its supply chain from grass to cow, thereby ensuring product quality [6][12]. - The company has been recognized with nominations for the China Quality Award, highlighting its commitment to excellence in the dairy sector [6]. Group 3: Social Impact - Feihe has created 170,000 jobs and increased the income of 160,000 farmers by integrating them into the dairy industry supply chain, demonstrating its commitment to shared prosperity [13]. - The company has donated nearly 850 million yuan to various social welfare initiatives, including education and healthcare, reflecting its dedication to community support [13]. - Feihe's narrative in the microfilms aligns with its mission to enhance national health and well-being, reinforcing its role as a trusted leader in the nutrition sector [9][12].

Core Viewpoint - Feihe and JD.com have launched two groundbreaking products, Jicui and Qicui, marking a significant innovation in the infant nutrition sector, aimed at meeting the nutritional needs of Chinese babies and leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][3]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing core consumer demands, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [3]. - Feihe's innovation includes the first-ever integration of "fresh raw materials" into the freshness standard of infant formula, creating a closed-loop system from fresh sources to self-produced active ingredients [3][5]. Group 2: Production and Quality - Feihe has achieved self-production capabilities for 11 key raw materials, enhancing freshness by at least 23 times and demonstrating a 6.4 times improvement in absorption [5]. - The products utilize fresh raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques ensuring superior quality [5][10]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national initiatives in breast milk research, accumulating significant findings that inform product development [8]. - The company holds three leading positions in the industry: first in breast milk research achievements, first in infant formula patents, and first in maternal source nutrition branding [8][10]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials before product launch, ensuring high standards of evidence for the efficacy of Jicui and Qicui [13]. - The clinical trials utilized RCT (randomized controlled trial) designs, achieving compliance with the highest global standards, thus validating the products' nutritional claims [13][16]. Group 5: Nutritional Benefits - Jicui's formula emphasizes a dual-source protective system, enhancing the baby's gut health and immune system, with evidence showing a 10.6% increase in the baby's immunoglobulin sIgA levels [10][17]. - Qicui focuses on brain development, incorporating a unique nutritional structure that mimics breast milk, leading to significant improvements in sleep patterns and cognitive development metrics [12][17]. Group 6: Market Positioning - The launch of Jicui and Qicui represents not just a formula upgrade but a strategic innovation tailored for Chinese infants, setting a new value benchmark in the infant formula industry [17]. - Feihe aims to continue providing products that support scientific nutrition, contributing to the future potential of children and the nation [17].